CALU_HUMAN - dbPTM
CALU_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CALU_HUMAN
UniProt AC O43852
Protein Name Calumenin
Gene Name CALU
Organism Homo sapiens (Human).
Sequence Length 315
Subcellular Localization Endoplasmic reticulum membrane . Golgi apparatus . Secreted . Melanosome . Sarcoplasmic reticulum lumen . Identified by mass spectrometry in melanosome fractions from stage I to stage IV.
Protein Description Involved in regulation of vitamin K-dependent carboxylation of multiple N-terminal glutamate residues. Seems to inhibit gamma-carboxylase GGCX. Binds 7 calcium ions with a low affinity (By similarity)..
Protein Sequence MDLRQFLMCLSLCTAFALSKPTEKKDRVHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAKTFDQLTPEESKERLGKIVSKIDGDKDGFVTVDELKDWIKFAQKRWIYEDVERQWKGHDLNEDGLVSWEEYKNATYGYVLDDPDPDDGFNYKQMMVRDERRFKMADKDGDLIATKEEFTAFLHPEEYDYMKDIVVQETMEDIDKNADGFIDLEEYIGDMYSHDGNTDEPEWVKTEREQFVEFRDKNRDGKMDKEETKDWILPSDYDHAEAEARHLVYESDQNKDGKLTKEEIVDKYDLFVGSQATDFGEALVRHDEF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4 (in isoform 14)Phosphorylation-22.4224043423
4 (in isoform 3)Phosphorylation-22.4224043423
4 (in isoform 4)Phosphorylation-22.4224043423
19 (in isoform 14)Phosphorylation-32.9124043423
19 (in isoform 3)Phosphorylation-32.9124043423
19 (in isoform 4)Phosphorylation-32.9124043423
22 (in isoform 14)Phosphorylation-65.2624043423
22 (in isoform 3)Phosphorylation-65.2624043423
22 (in isoform 4)Phosphorylation-65.2624043423
27 (in isoform 14)Phosphorylation-38.2524043423
27 (in isoform 3)Phosphorylation-38.2524043423
27 (in isoform 4)Phosphorylation-38.2524043423
35PhosphorylationVHHEPQLSDKVHNDA
CCCCCCHHHHHCCCH
30.0923927012
35O-linked_GlycosylationVHHEPQLSDKVHNDA
CCCCCCHHHHHCCCH
30.09OGP
37UbiquitinationHEPQLSDKVHNDAQS
CCCCHHHHHCCCHHH
41.85-
44PhosphorylationKVHNDAQSFDYDHDA
HHCCCHHHCCCCCHH
23.0820201521
47PhosphorylationNDAQSFDYDHDAFLG
CCHHHCCCCCHHCCC
17.1128355574
59UbiquitinationFLGAEEAKTFDQLTP
CCCHHHHCCHHHCCH
53.67-
60PhosphorylationLGAEEAKTFDQLTPE
CCHHHHCCHHHCCHH
39.2225159151
60O-linked_GlycosylationLGAEEAKTFDQLTPE
CCHHHHCCHHHCCHH
39.2251377199
60 (in isoform 2)Phosphorylation-39.2225159151
60 (in isoform 7)Phosphorylation-39.2225159151
60 (in isoform 8)Phosphorylation-39.2225159151
65PhosphorylationAKTFDQLTPEESKER
HCCHHHCCHHHHHHH
24.0325159151
65 (in isoform 2)Phosphorylation-24.0325159151
65 (in isoform 7)Phosphorylation-24.0325159151
65 (in isoform 8)Phosphorylation-24.0325159151
68 (in isoform 4)Phosphorylation-69.2125159151
69PhosphorylationDQLTPEESKERLGKI
HHCCHHHHHHHHHHH
37.8528355574
69 (in isoform 2)Phosphorylation-37.8525849741
69 (in isoform 7)Phosphorylation-37.8525849741
69 (in isoform 8)Phosphorylation-37.8525849741
70SumoylationQLTPEESKERLGKIV
HCCHHHHHHHHHHHH
50.57-
70UbiquitinationQLTPEESKERLGKIV
HCCHHHHHHHHHHHH
50.5721906983
70SumoylationQLTPEESKERLGKIV
HCCHHHHHHHHHHHH
50.57-
70 (in isoform 2)Ubiquitination-50.5721890473
73 (in isoform 15)Phosphorylation-9.57-
73 (in isoform 4)Phosphorylation-9.5725159151
75UbiquitinationESKERLGKIVSKIDG
HHHHHHHHHHHHHCC
44.52-
77 (in isoform 4)Phosphorylation-5.6325849741
78 (in isoform 1)Ubiquitination-27.6321890473
79UbiquitinationRLGKIVSKIDGDKDG
HHHHHHHHHCCCCCC
33.64-
79AcetylationRLGKIVSKIDGDKDG
HHHHHHHHHCCCCCC
33.6427452117
84UbiquitinationVSKIDGDKDGFVTVD
HHHHCCCCCCCEEHH
66.3421890473
89PhosphorylationGDKDGFVTVDELKDW
CCCCCCEEHHHHHHH
21.70-
92UbiquitinationDGFVTVDELKDWIKF
CCCEEHHHHHHHHHH
54.0721890473
94UbiquitinationFVTVDELKDWIKFAQ
CEEHHHHHHHHHHHH
49.3121890473
94 (in isoform 2)Ubiquitination-49.3121890473
98UbiquitinationDELKDWIKFAQKRWI
HHHHHHHHHHHHHHC
30.32983
98AcetylationDELKDWIKFAQKRWI
HHHHHHHHHHHHHHC
30.3227452117
102UbiquitinationDWIKFAQKRWIYEDV
HHHHHHHHHHCHHCH
46.39-
102UbiquitinationDWIKFAQKRWIYEDV
HHHHHHHHHHCHHCH
46.3921890473
106PhosphorylationFAQKRWIYEDVERQW
HHHHHHCHHCHHHHH
10.1025884760
106UbiquitinationFAQKRWIYEDVERQW
HHHHHHCHHCHHHHH
10.1021890473
111MethylationWIYEDVERQWKGHDL
HCHHCHHHHHCCCCC
47.73-
114UbiquitinationEDVERQWKGHDLNED
HCHHHHHCCCCCCCC
37.7221890473
122UbiquitinationGHDLNEDGLVSWEEY
CCCCCCCCCCCHHHH
23.0721890473
125PhosphorylationLNEDGLVSWEEYKNA
CCCCCCCCHHHHCCC
33.5425159151
129PhosphorylationGLVSWEEYKNATYGY
CCCCHHHHCCCCEEE
9.68-
130UbiquitinationLVSWEEYKNATYGYV
CCCHHHHCCCCEEEE
43.30-
131N-linked_GlycosylationVSWEEYKNATYGYVL
CCHHHHCCCCEEEEC
36.2919139490
150UbiquitinationPDDGFNYKQMMVRDE
CCCCCCHHHEEHHCH
32.59-
150 (in isoform 2)Ubiquitination-32.59-
162SulfoxidationRDERRFKMADKDGDL
HCHHHHCCCCCCCCE
5.5421406390
165AcetylationRRFKMADKDGDLIAT
HHHCCCCCCCCEEEE
54.8126051181
165UbiquitinationRRFKMADKDGDLIAT
HHHCCCCCCCCEEEE
54.81-
172PhosphorylationKDGDLIATKEEFTAF
CCCCEEEEHHHHHHH
31.8129083192
173UbiquitinationDGDLIATKEEFTAFL
CCCEEEEHHHHHHHC
46.34-
177PhosphorylationIATKEEFTAFLHPEE
EEEHHHHHHHCCHHH
21.5629083192
185PhosphorylationAFLHPEEYDYMKDIV
HHCCHHHHHHHHHHH
15.6529083192
187PhosphorylationLHPEEYDYMKDIVVQ
CCHHHHHHHHHHHHH
12.74-
188SulfoxidationHPEEYDYMKDIVVQE
CHHHHHHHHHHHHHH
2.6230846556
196PhosphorylationKDIVVQETMEDIDKN
HHHHHHHHHHHHHHC
14.5823663014
197SulfoxidationDIVVQETMEDIDKNA
HHHHHHHHHHHHHCC
4.2428465586
213 (in isoform 10)Phosphorylation-10.7923663014
217SulfoxidationLEEYIGDMYSHDGNT
HHHHHHHHCCCCCCC
2.8930846556
219 (in isoform 10)Phosphorylation-14.4123663014
224PhosphorylationMYSHDGNTDEPEWVK
HCCCCCCCCCCHHHH
47.47-
224O-linked_GlycosylationMYSHDGNTDEPEWVK
HCCCCCCCCCCHHHH
47.47OGP
248MethylationRDKNRDGKMDKEETK
HHCCCCCCCCHHHHC
48.49-
249SulfoxidationDKNRDGKMDKEETKD
HCCCCCCCCHHHHCC
12.4530846556
254PhosphorylationGKMDKEETKDWILPS
CCCCHHHHCCCCCCC
35.0823917254
255UbiquitinationKMDKEETKDWILPSD
CCCHHHHCCCCCCCC
55.112189047
255AcetylationKMDKEETKDWILPSD
CCCHHHHCCCCCCCC
55.1126051181
255 (in isoform 2)Ubiquitination-55.1121890473
261PhosphorylationTKDWILPSDYDHAEA
HCCCCCCCCCCHHHH
45.4120873877
261O-linked_GlycosylationTKDWILPSDYDHAEA
HCCCCCCCCCCHHHH
45.4162171197
263PhosphorylationDWILPSDYDHAEAEA
CCCCCCCCCHHHHHH
17.6123186163
263UbiquitinationDWILPSDYDHAEAEA
CCCCCCCCCHHHHHH
17.6121890473
275PhosphorylationAEARHLVYESDQNKD
HHHHHHHHHCCCCCC
18.9725884760
275NitrationAEARHLVYESDQNKD
HHHHHHHHHCCCCCC
18.97-
277PhosphorylationARHLVYESDQNKDGK
HHHHHHHCCCCCCCC
27.1528152594
281UbiquitinationVYESDQNKDGKLTKE
HHHCCCCCCCCCCHH
63.32-
287SumoylationNKDGKLTKEEIVDKY
CCCCCCCHHHHHHHH
64.88-
287SumoylationNKDGKLTKEEIVDKY
CCCCCCCHHHHHHHH
64.88-
287UbiquitinationNKDGKLTKEEIVDKY
CCCCCCCHHHHHHHH
64.88-
293UbiquitinationTKEEIVDKYDLFVGS
CHHHHHHHHCEEEEC
29.75-
300PhosphorylationKYDLFVGSQATDFGE
HHCEEEECCCCCHHH
16.0223663014
300O-linked_GlycosylationKYDLFVGSQATDFGE
HHCEEEECCCCCHHH
16.02OGP
303PhosphorylationLFVGSQATDFGEALV
EEEECCCCCHHHHHH
24.9923663014
303O-linked_GlycosylationLFVGSQATDFGEALV
EEEECCCCCHHHHHH
24.99OGP

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
44SPhosphorylationKinasePLK2Q9NYY3
PSP
44SPhosphorylationKinasePLK3Q9H4B4
PSP
60TPhosphorylationKinasePLK2Q9NYY3
PSP
60TPhosphorylationKinasePLK3Q9H4B4
PSP
69SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot
73TPhosphorylationKinaseCSNK2A1P68400
GPS
177TPhosphorylationKinasePLK3Q9H4B4
PSP
196TPhosphorylationKinasePLK2Q9NYY3
PSP
196TPhosphorylationKinasePLK3Q9H4B4
PSP
254TPhosphorylationKinasePLK3Q9H4B4
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CALU_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CALU_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SAMP_HUMANAPCSphysical
10631319
LYAG_HUMANGAAphysical
22939629
SYSM_HUMANSARS2physical
22939629
TM256_HUMANTMEM256physical
22939629
FAF2_HUMANFAF2physical
22939629
PTBP3_HUMANPTBP3physical
22939629
DREB_HUMANDBN1physical
22939629
EMC1_HUMANEMC1physical
22939629
ICT1_HUMANICT1physical
22939629
TM165_HUMANTMEM165physical
22939629
RL32_HUMANRPL32physical
22939629
PERI_HUMANPRPHphysical
22939629
PPT2_HUMANPPT2physical
22939629
EGFR_HUMANEGFRphysical
22939629
RL21_HUMANRPL21physical
22939629
SYIM_HUMANIARS2physical
22939629
CAVN3_HUMANPRKCDBPphysical
22939629
CTNL1_HUMANCTNNAL1physical
21988832
UMPS_HUMANUMPSphysical
21988832
ZPBP1_HUMANZPBPphysical
21988832
ANM5_HUMANPRMT5physical
23455924
SYAC_HUMANAARSphysical
22863883
AASD1_HUMANAARSD1physical
22863883
ARC1B_HUMANARPC1Bphysical
22863883
ARPC2_HUMANARPC2physical
22863883
ARPC3_HUMANARPC3physical
22863883
ARPC4_HUMANARPC4physical
22863883
ARP5L_HUMANARPC5Lphysical
22863883
DPP8_HUMANDPP8physical
22863883
EF2K_HUMANEEF2Kphysical
22863883
HSF1_HUMANHSF1physical
22863883
IPO11_HUMANIPO11physical
22863883
KBP_HUMANKIAA1279physical
22863883
METH_HUMANMTRphysical
22863883
NIF3L_HUMANNIF3L1physical
22863883
NSUN2_HUMANNSUN2physical
22863883
KAPCA_HUMANPRKACAphysical
22863883
KAP1_HUMANPRKAR1Bphysical
22863883
RAGP1_HUMANRANGAP1physical
22863883
TM10A_HUMANTRMT10Aphysical
22863883
RFA2_HUMANRPA2physical
22863883
RPR1B_HUMANRPRD1Bphysical
22863883
SAE1_HUMANSAE1physical
22863883
SH3G1_HUMANSH3GL1physical
22863883
SHLB1_HUMANSH3GLB1physical
22863883
SHLB2_HUMANSH3GLB2physical
22863883
THG1_HUMANTHG1Lphysical
22863883
PRPK_HUMANTP53RKphysical
22863883
TPD54_HUMANTPD52L2physical
22863883
TPRKB_HUMANTPRKBphysical
22863883
UBQL1_HUMANUBQLN1physical
25416956
OBSL1_HUMANOBSL1physical
26186194
CALR_HUMANCALRphysical
26344197
ENPL_HUMANHSP90B1physical
26344197
HS74L_HUMANHSPA4Lphysical
26344197
NACA2_HUMANNACA2physical
26344197
TKT_HUMANTKTphysical
26344197
HIC2_HUMANHIC2physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CALU_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-131, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND THR-65, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-65, AND MASSSPECTROMETRY.

TOP